Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
CBER’s ‘Courageous’ Coronavirus Guidance Strategy May Catch-On
Jun 26 2020
•
By
Derrick Gingery
CBER staff realized that writing guidance faster does not mean the recommendations will be lower quality , Director Peter Marks said. • Source: Shutterstock
More from US FDA
More from Agency Leadership